ISSN 1357-0560
Publisher: Humana Press
< previous issue | all issues
Should adjuvant trastuzumab be offered in very early-stage (pT1a/bN0M0) HER2-neu-positive breast cancer? A current debate pp. 401-408(8) Authors: Petrelli, Fausto; Barni, Sandro
Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey pp. 409-415(7) Authors: Basaran, Gul; Turhal, Nazım; Cabuk, Devrim; Yurt, Nevin; Yurtseven, Gul; Gumus, Mahmut; Teomete, Mehmet; Dane, Faysal; Yumuk, Perran
Prolonged time to progression with fulvestrant for metastatic breast cancer pp. 416-419(4) Authors: Mello, Celso; Chinen, Ludmilla; da Silva, Samantha; do Nascimento Matias, Carolina; Benevides, Carlos; Gimenes, Daniel; Fanelli, Marcello
Association of sporadic breast cancer with PTEN/MMAC1/TEP1 promoter hypermethylation pp. 420-423(4) Authors: Sadeq, Vallian; Isar, Nassiri; Manoochehr, Tavassoli
Lack of significant association between TGF-β1 -590C/T polymorphism and breast cancer risk: a meta-analysis pp. 424-428(5) Authors: Huang, Yongsheng; Hao, Youjin; Li, Binghui; Xie, Jingtian; Qian, Ji; Chao, Chen; Yu, Long
Experience in large-core needle biopsy in the diagnosis of 1431 breast lesions pp. 429-433(5) Authors: Wei, Xi; Li, Ying; Zhang, Sheng; Zhu, Ying; Fan, Yu
A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer pp. 434-440(7) Authors: Hashimoto, Kenji; Yonemori, Kan; Shimizu, Chikako; Hirakawa, Akihiro; Yamamoto, Harukaze; Ono, Makiko; Hirata, Taizo; Kouno, Tsutomu; Tamura, Kenji; Katsumata, Noriyuki; Ando, Masashi; Fujiwara, Yasuhiro
Reproductive factors associated with breast cancer risk in northern Iran pp. 441-446(6) Authors: Hajian-Tilaki, K.; Kaveh-Ahangar, T.
Pathobiologic implications of methylation and expression status of Runx3 and CHFR genes in gastric cancer pp. 447-454(8) Authors: Hu, Shi-Lian; Huang, Da-Bing; Sun, Yu-Bei; Wu, Lei; Xu, Wei-Ping; Yin, Shi; Chen, Jiong; Jiang, Xiao-Dong; Shen, Gan
Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer pp. 455-462(8) Authors: Jian-bo, Xu; Hui, Wu; Yu-long, He; Chang-hua, Zhang; Long-juan, Zhang; Shi-rong, Cai; Wen-hua, Zhan
Painless acute pancreatitis associated with sorafenib treatment: a case report pp. 463-465(3) Authors: Kobayashi, Yasuyuki; Kanemitu, Toshiyuki; Kamoto, Akihito; Satoh, Mototaka; Mori, Naoki; Sekii, Kenichiro; Yoshioka, Toshiaki; Itatani, Hiroaki; Fujimoto, Takashi
Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer pp. 466-474(9) Authors: Duan, Xiaohui; Deng, Langmei; Chen, Xiong; Lu, Yebin; Zhang, Qi; Zhang, Kejing; Hu, Yongjun; Zeng, Jie; Sun, Weijia
ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients pp. 475-480(6) Authors: Wu, Kai; Liao, Mingmei; Liu, Bo; Deng, Zhansheng
Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma pp. 481-487(7) Authors: Zhang, Jin; Dong, Wei-guo; Lin, Jun
Evaluation of efficacy and safety of generic levofolinate in patients who received colorectal cancer chemotherapy pp. 488-493(6) Authors: Fujii, Hironori; Iihara, Hirotoshi; Yasuda, Koji; Matsuura, Katsuhiko; Takahashi, Takao; Yoshida, Kazuhiro; Itoh, Yoshinori
Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA pp. 494-501(8) Authors: Zhang, Jin; Liu, Qi-Sheng; Dong, Wei-Guo
Expression and significance of Cx43 and E-cadherin in gastric cancer and metastatic lymph nodes pp. 502-508(7) Authors: Tang, Bo; Peng, Zhi-Hong; Yu, Pei-Wu; Yu, Ge; Qian, Feng
Neuroendocrine carcinoma of the esophagus: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA pp. 509-512(4) Author: Terada, Tadashi
The clinical relevance of urine-based markers for diagnosis of bladder cancer pp. 513-518(6) Authors: Eissa, Sanaa; Swellam, Menha; Amin, Amr; Balbaa, Mohamed; Yacout, Galila; El-Zayat, Tarek
Health-related quality of life assessment in prospective trials of systemic cytotoxic chemotherapy for metastatic castration-resistant prostate cancer: which instrument we need? pp. 519-527(9) Authors: Colloca, Giuseppe; Colloca, Pasquale
Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death pp. 528-531(4) Authors: Chen, Rui; Xiao, Wei; Li, Ding; Mu, Shijie
Alemtuzumab maintenance may safely prolong chemotherapy-free intervals in chronic lymphocytic leukemia pp. 532-538(7) Authors: Kaufman, Matthew; Caramanica, Angelica; Janson, Dale; Driscoll, Nancy; Johnson, Christina; Kohn, Nina; Wasil, Tarun; Rai, Kanti
Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma pp. 539-543(5) Authors: Machaczka, Maciej; Vaktnäs, Johan; Klimkowska, Monika; Nahi, Hareth; Hägglund, Hans
Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features pp. 544-551(8) Authors: Chauhan, Pradeep; Bhushan, Bharat; Mishra, Ashwani; Singh, Laishram; Saluja, Sumita; Verma, Saurabh; Gupta, Dipendra; Mittal, Vishakha; Chaudhry, Sumita; Kapur, Sujala
Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts pp. 552-558(7) Authors: Wahlin, Anders; Lorenz, Fryderyk; Fredriksson, Maritha; Remberger, Mats; Wahlin, Björn; Hägglund, Hans
Metastin is not involved in metastatic potential of non-small cell lung cancer pp. 559-564(6) Authors: Karapanagiotou, Eleni; Dilana, Kalliopi; Gkiozos, Ioannis; Gratsias, Ioannis; Tsimpoukis, Sotirios; Polyzos, Aris; Syrigos, Kostas
Rho kinase inhibitor fasudil suppresses migration and invasion though down-regulating the expression of VEGF in lung cancer cell line A549 pp. 565-571(7) Authors: Zhu, Fang; Zhang, Zhe; Wu, Gang; Li, Zhenyu; Zhang, Ruiguang; Ren, Jinghua; Nong, Li
BIM induction of apoptosis triggered by EGFR-sensitive and resistance cell lines of non-small-cell lung cancer pp. 572-577(6) Authors: Li, Zhanxia; Zhou, Songwen; Zhang, Ling; Su, Chunxia; Hang, Jinqin; Zhao, Yinmin; Su, Bo; Zhou, Caicun
Sunitinib in pretreated advanced non-small-cell lung carcinoma: a primary result from Asian population pp. 578-583(6) Authors: Ping, Gu; Hui-Min, Wang; Wei-Min, Wang; Bao-Hui, Han
Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study pp. 584-590(7) Authors: Sabry, Nirmeen; Habib, Emad
Gemcitabine and cisplatin in patients with carcinoma of unknown primary site pp. 591-596(6) Authors: Isik, Metin; Seker, Mehmet; Odabas, Hatice; Kos, Fahriye; Uncu, Dogan; Zengin, Nurullah
The invasive malignancy from peritoneal epithelial cell: a report of four cases and review of literature pp. 597-600(4) Authors: Hongjian, Xue; Jiquan, Fan; Gang, Peng; Rubo, Cao
Growth inhibitory effects of DJ-1-small interfering RNA on laryngeal carcinoma Hep-2 cells pp. 601-607(7) Authors: Shen, Zhisen; Jiang, Zhen; Ye, Dong; Xiao, Bingxiu; Zhang, Xingang; Guo, Junming
β-Catenin overexpression in malignant glioma and its role in proliferation and apoptosis in glioblastma cells pp. 608-614(7) Authors: Liu, Xiangrong; Wang, Lei; Zhao, Shangfeng; Ji, Xunming; Luo, Yumin; Ling, Feng
The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats pp. 615-621(7) Authors: Paksoy, Mustafa; Ayduran, Emin; Şanlı, Arif; Eken, Mehmet; Aydın, Sedat; Oktay, Zeynep
Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population pp. 622-625(4) Authors: Hu, Yun-Sheng; Pan, Yong; Li, Wen-Hai; Zhang, Yong; Li, Jun; Ma, Bao-An
EpCAM-autoantibody levels in the course of disease of ovarian cancer patients pp. 626-630(5) Authors: Heubner, Martin; Errico, Dino; Kasimir-Bauer, Sabine; Herlyn, Dorothee; Kimmig, Rainer; Wimberger, Pauline
The role of Pygopus 2 in rat glioma cell growth pp. 631-640(10) Authors: Chen, Yu-ying; Li, Bo-an; Wang, Hai-dong; Liu, Xi-yao; Tan, Guo-wei; Ma, Yong-hui; Shen, Shang-hang; Zhu, Hong-wei; Wang, Zhan-xiang
Golimumab and malignancies: true or false association? pp. 641-648(8) Authors: Zidi, Ines; Bouaziz, Aicha; Mnif, Wissem; Bartegi, Aghleb; Ben Amor, Nidhal
Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma pp. 649-653(5) Authors: Lin, Feng; Zheng, Shui-er; Shen, Zan; Tang, Li-na; Chen, Ping; Sun, Yuan-jue; Zhao, Hui; Yao, Yang